GlassScriptPhysician profile
Rakendu Shukla
NPI 1316387137
$929.44
in general payments reported to CMS, 2019-2025
16 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.10 · 2022: $181 · 2023: $129 · 2024: $435 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $715.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $163.55 | 2022-2024 | Somatom Go.Top, Bravos Afterloader System |
| Teleflex LLC | $128.89 | 2024 | |
| Depuy Synthes Sales INC. | $122.73 | 2025 | Trumatch |
| Novocure INC. | $86.00 | 2021-2024 | Optune |
| Daiichi Sankyo INC. | $69.66 | 2023-2024 | Enhertu |
| Merck Sharp & Dohme LLC | $66.50 | 2024 | Keytruda |
| Regeneron Healthcare Solutions, INC. | $61.38 | 2023-2025 | Libtayo |
| Jazz Pharmaceuticals INC. | $50.54 | 2024 | |
| Janssen Biotech, INC. | $30.26 | 2024 | Rybrevant |
| Acrotech Biopharma INC. | $27.93 | 2024 | Beleodaq |
| Exelixis INC. | $24.49 | 2024 | Cabometyx |
| G1 Therapeutics, INC. | $23.76 | 2023 | Cosela |
| Eisai INC. | $20.22 | 2024 | |
| Stemline Therapeutics INC. | $19.36 | 2023 | Orserdu |
| Celgene Corporation | $17.16 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $17.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rakendu Shukla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.